H. Harma et al., Europium nanoparticles and time-resolved fluorescence for ultrasensitive detection of prostate-specific antigen, CLIN CHEM, 47(3), 2001, pp. 561-568
Background: Nanoparticle-based detection technologies have the potential to
improve detection sensitivity in miniature as well as in conventional bioc
hemical assays. We introduce a detection technology that relies on the use
of europium(III) nanoparticles and time-resolved fluorometry to improve the
detection limit of biochemical assays and to visualize individual molecule
s in a microtiter plate format.
Methods: Streptavidin was covalently coated on 107-nm nanoparticles contain
ing >30 000 europium molecules entrapped with P-diketones. In a model assay
system, these nanoparticles were used to trace biotinylated prostate-speci
fic antigen (PSA) in a microtiter plate format.
Results: The detection limit (mean + 3 SD of the zero calibrator) of biotin
ylated PSA was 0.38 ng/L, corresponding to 10 fmol/L or 60 zeptomoles (60 x
10(-21) moles) of PSA. Moreover, single nanoparticles, representing indivi
dual PSA molecules, were visualized in the same microtiter wells with a tim
e-resolved fluorescence microscope using a x10 objective. Single nanopartic
les, possessing high specific activity, were also detected in solution by a
standard time-resolved plate fluorometer.
Conclusions: The universal streptavidin-coated europium(III) nanoparticle l
abel is suitable for detection of any biotinylated molecule either in solut
ion or on a solid phase. The europium(III) nanoparticle labeling technology
is applicable to many areas of modern biochemical analysis, such as immuno
chemical and multianalyte DNA-chip assays as well as histo- and cytochemist
ry to improve detection sensitivities. (C) 2001 American Association for Cl
inical Chemistry.